Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 41,496 | 6,425 | 101,259 | 110,881 | 111,061 |
| Depreciation Amortization | 16,303 | 8,015 | 36,006 | 30,482 | 24,179 |
| Income taxes - deferred | -4,786 | -2,879 | -21,132 | -13,996 | -6,873 |
| Accounts receivable | -50,903 | -6,528 | -20,744 | -41,257 | -11,231 |
| Other Working Capital | -62,800 | -36,729 | -11,045 | -23,518 | 126 |
| Other Operating Activity | 73,110 | 14,620 | 65,596 | 92,674 | 51,882 |
| Operating Cash Flow | $12,420 | $-17,076 | $149,940 | $155,266 | $169,144 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,946 | -32,311 | -71,106 | -46,243 | -72,336 |
| PPE Investments | -18,271 | -9,782 | -32,785 | -24,222 | -20,075 |
| Purchase Sale Intangibles | N/A | -2,000 | -12,000 | N/A | N/A |
| Other Investing Activity | -3,000 | -2,000 | -12,000 | 0 | 0 |
| Investing Cash Flow | $-46,217 | $-44,093 | $-115,891 | $-70,465 | $-92,411 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,660 | 5,977 | 8,213 | 5,882 | 4,351 |
| Other Financing Activity | 1,507 | 920 | 749 | 742 | 446 |
| Financing Cash Flow | $9,167 | $6,897 | $8,962 | $6,624 | $4,797 |
| Exchange Rate Effect | -843 | -968 | -561 | -458 | -709 |
| Beginning Cash Position | 184,612 | 184,612 | 142,162 | 142,162 | 142,162 |
| End Cash Position | 159,139 | 129,372 | 184,612 | 233,129 | 222,983 |
| Net Cash Flow | $-25,473 | $-55,240 | $42,450 | $90,967 | $80,821 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,420 | -17,076 | 149,940 | 155,266 | 169,144 |
| Capital Expenditure | -18,271 | -9,782 | -32,785 | -24,222 | -20,075 |
| Free Cash Flow | -5,851 | -26,858 | 117,155 | 131,044 | 149,069 |